Human trials for varied use of ED drugs

22 December, 2005

Pfizer, the manufacturer of erectile dysfunction (ED) drug Viagra has commenced clinical trials in India on certain new uses of sildenafil citrate, the active ingredient found in its blockbuster erectile dysfunction drug Viagra, at 4 to 5 sites in India. This particular step taken Pfizer indicates that the company may launch its Revatio here.

Revatio is a drug which was approved by the USFDA in June this year and it uses the same ingredient as the ED drug Viagra, according to industry sources. Revatio is used to treat pulmonary arterial hypertension (PAH), a rare, aggressive and life-shortening vascular disease. Multinationals who plan to launch their drug in India have to register the drug with the Drug Controller General of India.

To read more, visit:
http://www.financialexpress.com/fe_full_story.php?content_id=112229